United Parcel Service Inc (UPS) Stock News

UPS is investing $48 million in 27 temperature-controlled facilities to serve the healthcare sector, particularly for GLP-1 weight-loss drugs and temperature-sensitive medications. This strategic shift is part of the company's broader turnaround effort to move away from low-margin customers toward high-margin healthcare customers. Management expects the second half of 2026 to be an inflection point, with revenue per package rising despite lower overall revenue.

United Parcel Service (UPS) stock has recovered 30% from October 2025 lows and is positioned for a turnaround. The analyst recommends buying before July 15 earnings report, as the company expects weak first-half 2026 results but projects stronger second-half performance. Management has indicated the inflection point will occur at the end of Q2, with revenue per piece already showing steady increases as a sign of early turnaround success.

A securities class action lawsuit has been filed against Upstart Holdings, Inc. alleging that the company made false and misleading statements about its Model 22 AI risk assessment tool. The lawsuit claims the model frequently overreacted to negative economic signals, overstating accuracy and loan approval rates, which negatively impacted revenue and made 2025 guidance unreliable. Investors who purchased UPST securities between May 14, 2025 and November 4, 2025 may be eligible for compensation. The lead plaintiff deadline is June 8, 2026.

Rosen Law Firm is reminding investors in Upstart Holdings who purchased securities between May 14, 2025 and November 4, 2025 of an important June 8, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Upstart made false and misleading statements regarding its Model 22 AI risk assessment tool, claiming it frequently overreacted to negative economic signals, overstated accuracy, and negatively impacted revenue results, rendering the company's 2025 guidance unreliable.

A class action lawsuit has been filed against Upstart Holdings for alleged securities fraud. The complaint alleges that defendants made false statements about Model 22's accuracy and loan approval rates. The truth emerged on November 4, 2025, when Upstart reported Q3 revenue of $277 million, missing guidance, and revealed that Model 22 had overreacted to macroeconomic signals, reducing approvals. The stock fell 9.71% following the disclosure.

Upstart Holdings faces a securities class action lawsuit after allegedly inflating AI model performance projections. The company's flagship AI underwriting model suppressed loan approvals in Q3 2025, leading to a $4.49 per share (9.71%) decline and a $44 million revenue guidance cut. Institutional investors who purchased shares between May 14, 2025 and November 4, 2025 may seek lead plaintiff status by the June 8, 2026 deadline.

Rosen Law Firm is notifying investors in Upstart Holdings, Inc. (NASDAQ: UPST) of a June 8, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Upstart made false and misleading statements regarding its Model 22 AI risk assessment tool, claiming it frequently overreacted to negative macroeconomic signals, overstated accuracy, and negatively impacted revenue results, rendering the company's 2025 revenue guidance unreliable.

A securities class action lawsuit has been filed against Upstart, Inc. alleging that the company issued materially false and misleading statements regarding its AI Model 22. The complaint claims the model frequently overreacted to negative macroeconomic signals, leading to overstated accuracy claims and overly conservative credit assessments that negatively impacted revenue. The deadline for lead plaintiff registration is June 8, 2026.

A securities class action lawsuit has been filed against Upstart Holdings, Inc. (NASDAQ: UPST) alleging that the company made false and misleading statements regarding its Model 22 AI risk assessment tool. The lawsuit claims the model frequently overreacted to negative macroeconomic signals, leading to overstated accuracy claims and inflated revenue guidance for 2025. Investors who purchased UPST securities between May 14, 2025 and November 4, 2025 may be eligible to join the class action with a lead plaintiff deadline of June 8, 2026.

Rosen Law Firm is urging investors who purchased Upstart Holdings (NASDAQ: UPST) securities between May 14, 2025 and November 4, 2025 to join a class action lawsuit. The lawsuit alleges that Upstart made false statements about its Model 22 AI risk assessment tool, claiming it frequently overreacted to negative economic signals, overstated accuracy, and negatively impacted revenue guidance. The lead plaintiff deadline is June 8, 2026.

A securities class action lawsuit has been filed against Upstart Holdings, Inc. (NASDAQ: UPST) alleging that the company made false and misleading statements regarding its Model 22 AI risk assessment tool. The lawsuit claims the model frequently overreacted to negative macroeconomic signals, leading to overstated accuracy claims and inflated revenue guidance for 2025. Investors who purchased UPST securities between May 14, 2025 and November 4, 2025 may be eligible for compensation. The lead plaintiff deadline is June 8, 2026.

Robbins LLP has filed a class action lawsuit against Upstart Holdings, Inc. on behalf of investors who purchased securities between May 14, 2025 and November 4, 2025. The lawsuit alleges that Upstart misled investors about its AI lending model (Model 22), claiming it overstated the model's accuracy and loan approval rate increases while failing to disclose that the model was overly conservative and negatively impacting revenue. The company missed Q3 2025 revenue guidance and significantly reduced its FY 2025 revenue outlook, causing the stock to fall 9.71% on November 5, 2025.

A class action lawsuit has been filed against Upstart Holdings, Inc. for allegedly making false and misleading statements about its Model 22 AI risk assessment tool. The lawsuit claims the model frequently overreacted to negative macroeconomic signals, overstated accuracy, and negatively impacted revenue results, rendering the company's 2025 guidance unreliable. Investors who purchased Upstart securities between May 14, 2025 and November 4, 2025 can seek damages.

A class action lawsuit has been filed against Upstart Holdings, Inc. for alleged securities fraud. The complaint alleges that Upstart made false statements about its AI lending model (Model 22), overstating its accuracy and approval rates. The company's stock fell 9.71% after revealing on November 4, 2025, that Model 22 had overreacted to macroeconomic signals, reducing approvals and forcing significant downward revisions to full-year revenue guidance.

UPS is executing a strategic pivot to reduce Amazon deliveries by 50% and shift toward higher-margin customers, including small and medium-sized businesses and healthcare products. Despite near-term headwinds from trade tensions and macro weakness, the company is showing incremental improvements with rising SMB volumes and record healthcare revenue. With a forward P/E of 14x and 6.6% dividend yield, UPS presents a buying opportunity as its turnaround gains momentum.

Rosen Law Firm is urging investors who purchased Upstart Holdings (UPST) securities between May 14, 2025 and November 4, 2025 to join a class action lawsuit. The lawsuit alleges that Upstart made false statements about its Model 22 AI system, claiming it frequently overreacted to negative economic signals, overstated accuracy, and negatively impacted revenue guidance. The lead plaintiff deadline is June 8, 2026.

Upstart Holdings faces a securities class action lawsuit after allegedly inflating AI model performance projections. The company's flagship AI underwriting model suppressed loan approvals in Q3 2025, leading to a $4.49 per share (9.71%) decline and a $44 million revenue guidance cut. Institutional investors who purchased shares between May 14, 2025 and November 4, 2025 may seek lead plaintiff status by June 8, 2026.

A securities fraud class action lawsuit has been filed against Upstart Holdings, Inc. on behalf of investors who purchased securities between May 14, 2025 and November 4, 2025. The lawsuit alleges that the company's AI Model 22 frequently overreacted to negative macroeconomic signals, causing overstated accuracy claims and reduced loan approvals. On November 5, 2025, Upstart disclosed it missed Q3